Cargando…

Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine

BACKGROUND: Lipid metabolism may be altered in red cell genetic disorders. The erythrocyte and plasma lipids are defected which may increase the risk of cardiovascular disease. In the present study, we hypothesized a possible link between severity of anemia and altered lipid profile in SCD. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Samarah, Fekri, Srour, Mahmoud A., Dumaidi, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360734/
https://www.ncbi.nlm.nih.gov/pubmed/34395622
http://dx.doi.org/10.1155/2021/6640956
_version_ 1783737803419418624
author Samarah, Fekri
Srour, Mahmoud A.
Dumaidi, Kamal
author_facet Samarah, Fekri
Srour, Mahmoud A.
Dumaidi, Kamal
author_sort Samarah, Fekri
collection PubMed
description BACKGROUND: Lipid metabolism may be altered in red cell genetic disorders. The erythrocyte and plasma lipids are defected which may increase the risk of cardiovascular disease. In the present study, we hypothesized a possible link between severity of anemia and altered lipid profile in SCD. METHODS: A total of 151 SCD patients, including 62 patients with sickle cell anemia (SS), 54 patients with sickle β-thalassemia (ST), and 35 individuals with sickle cell trait (AS), were studied. The control group consisted of 160 healthy individuals. Total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were enzymatically measured. RESULTS: Total cholesterol and LDL-C were significantly lower (P value < 0.001) in SS and ST patients compared to AS individuals and AA controls. However, LDL-C was significantly lower in AS individuals (both males and female) compared to AA controls (P value < 0.001). The HDL-C in SS and ST patients (both males and females) was significantly lower than that in AS individuals (P value < 0.001). In addition, the HDL-C was significantly higher in SS and ST males and AS (males and females) compared to AA controls (P value < 0.001). The HDL-C was also significantly higher in SS males (P value < 0.001) and females (P value < 0.05) compared to ST patients. The HDL-C was significantly higher in AS individuals (P value < 0.001) compared to AA controls. The triglycerides in SS males was significantly lower than that in ST patients (P value < 0.001), but there was no significant difference when compared to AS individuals and AA controls. In contrast, triglycerides in SS females were significantly lower than those in ST (P value < 0.05), AS (P value < 0.001), and AA controls (P value < 0.001). In males of ST patients, triglycerides were significantly higher than those observed in AS males and AA males (P value < 0.001). In contrast, females of ST patients have a significantly lower triglycerides compared to AS and AA females (P value < 0.001). CONCLUSIONS: In SCD, the plasma is affected in some way, especially the plasma cholesterol that was investigated in this study. Further prospective studies should examine the contribution of an altered lipid profile to the severity and clinical complications in SCD patients.
format Online
Article
Text
id pubmed-8360734
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-83607342021-08-13 Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine Samarah, Fekri Srour, Mahmoud A. Dumaidi, Kamal Biomed Res Int Research Article BACKGROUND: Lipid metabolism may be altered in red cell genetic disorders. The erythrocyte and plasma lipids are defected which may increase the risk of cardiovascular disease. In the present study, we hypothesized a possible link between severity of anemia and altered lipid profile in SCD. METHODS: A total of 151 SCD patients, including 62 patients with sickle cell anemia (SS), 54 patients with sickle β-thalassemia (ST), and 35 individuals with sickle cell trait (AS), were studied. The control group consisted of 160 healthy individuals. Total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were enzymatically measured. RESULTS: Total cholesterol and LDL-C were significantly lower (P value < 0.001) in SS and ST patients compared to AS individuals and AA controls. However, LDL-C was significantly lower in AS individuals (both males and female) compared to AA controls (P value < 0.001). The HDL-C in SS and ST patients (both males and females) was significantly lower than that in AS individuals (P value < 0.001). In addition, the HDL-C was significantly higher in SS and ST males and AS (males and females) compared to AA controls (P value < 0.001). The HDL-C was also significantly higher in SS males (P value < 0.001) and females (P value < 0.05) compared to ST patients. The HDL-C was significantly higher in AS individuals (P value < 0.001) compared to AA controls. The triglycerides in SS males was significantly lower than that in ST patients (P value < 0.001), but there was no significant difference when compared to AS individuals and AA controls. In contrast, triglycerides in SS females were significantly lower than those in ST (P value < 0.05), AS (P value < 0.001), and AA controls (P value < 0.001). In males of ST patients, triglycerides were significantly higher than those observed in AS males and AA males (P value < 0.001). In contrast, females of ST patients have a significantly lower triglycerides compared to AS and AA females (P value < 0.001). CONCLUSIONS: In SCD, the plasma is affected in some way, especially the plasma cholesterol that was investigated in this study. Further prospective studies should examine the contribution of an altered lipid profile to the severity and clinical complications in SCD patients. Hindawi 2021-08-04 /pmc/articles/PMC8360734/ /pubmed/34395622 http://dx.doi.org/10.1155/2021/6640956 Text en Copyright © 2021 Fekri Samarah et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Samarah, Fekri
Srour, Mahmoud A.
Dumaidi, Kamal
Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
title Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
title_full Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
title_fullStr Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
title_full_unstemmed Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
title_short Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
title_sort plasma lipids and lipoproteins in sickle cell disease patients in the northern west bank, palestine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360734/
https://www.ncbi.nlm.nih.gov/pubmed/34395622
http://dx.doi.org/10.1155/2021/6640956
work_keys_str_mv AT samarahfekri plasmalipidsandlipoproteinsinsicklecelldiseasepatientsinthenorthernwestbankpalestine
AT srourmahmouda plasmalipidsandlipoproteinsinsicklecelldiseasepatientsinthenorthernwestbankpalestine
AT dumaidikamal plasmalipidsandlipoproteinsinsicklecelldiseasepatientsinthenorthernwestbankpalestine